Patients typically receive semaglutide injections weekly, and the dosage depends on your doctors recommendations and how your body responds
Gallbladder Issues: Rapid weight loss can sometimes cause gallstones
Systemic manifestations potentially suggesting reduced efficacy may include: Unexplained loss of glycemic control in patients with type 2 diabetes, evidenced by rising hemoglobin A1c or fasting glucose levels Diminished appetite suppression or return of hunger despite continued treatment Weight loss plateau or weight regain without changes in diet or activity Reduced gastrointestinal effects that were previously present It's important to note that these systemic signs are non-specific and may reflect medication storage issues, injection technique problems, treatment adaptation, or disease progression rather than antibody formation
If you are already on a GLP-1 medication, nutritional support through a science-backed supplement can help address nutrient gaps from reduced food intake
Feng P, Sheng X, Ji Y, Urva S, Wang F, Miller S, et al
PMID 36129996